Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Weil

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Breast Cancer Research : BCR|August 19, 2025
Evaluation and management of incomplete ovarian function suppression in premenopausal breast cancer patients receiving anti-hormone therapyRuchi Patel, Elizabeth Weil, Sara Bugamelli, et al.
Research Square|April 17, 2023
Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine TherapyLubna Naaz Chaudhary, Julie Jorns, Yunguang Sun, et al.
Breast Cancer Research and Treatment|July 17, 2023
Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapyLubna N Chaudhary, Julie M Jorns, Yunguang Sun, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Breast Cancer Research : BCR|August 19, 2025
Evaluation and management of incomplete ovarian function suppression in premenopausal breast cancer patients receiving anti-hormone therapyRuchi Patel, Elizabeth Weil, Sara Bugamelli, et al.
Research Square|April 17, 2023
Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine TherapyLubna Naaz Chaudhary, Julie Jorns, Yunguang Sun, et al.
Breast Cancer Research and Treatment|July 17, 2023
Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapyLubna N Chaudhary, Julie M Jorns, Yunguang Sun, et al.
Pageof 2